Heres a closer look at the four major GLP-1 drugs on the market (Ozempic, Mounjaro, Wegovy, and Zepbound): Of these medications, only Zepbound (known generically as tirzepatide) is FDA-approved to treat sleep apnea in those with a body mass index (BMI) of 30 or higher
This peptide appears to promote angiogenesisthe formation of new blood vesselswhich can enhance blood flow and optimize the delivery of oxygen and nutrients to injured tissues
Studies 80,81,82,83 reported a 1.7%3.32% and 1.5%8% reduction in femoral neck and total hip BMD, respectively, in male patients at 612 months postoperatively, attributing these changes to decreased mechanical loading from weight loss
Carbohydrate consistency is important
This led researchers to investigate liraglutide as a stand-alone treatment for obesity